1. Home
  2. AEIS vs IBRX Comparison

AEIS vs IBRX Comparison

Compare AEIS & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advanced Energy Industries Inc.

AEIS

Advanced Energy Industries Inc.

N/A

Current Price

$224.53

Market Cap

8.9B

Sector

Technology

ML Signal

N/A

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

N/A

Current Price

$8.00

Market Cap

8.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AEIS
IBRX
Founded
1981
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9B
8.2B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
AEIS
IBRX
Price
$224.53
$8.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
4
Target Price
★ $415.00
$14.25
AVG Volume (30 Days)
573.7K
★ 13.3M
Earning Date
11-02-2026
11-13-2026
Dividend Yield
★ 0.18%
N/A
EPS Growth
★ 168.53
38.71
EPS
★ 2.86
N/A
Revenue
★ $453,095,000.00
$113,288,000.00
Revenue This Year
$34.79
$99.98
Revenue Next Year
$24.79
$108.29
P/E Ratio
$77.66
★ N/A
Revenue Growth
38.39
★ 668.31
52 Week Low
$187.71
$1.95
52 Week High
$397.44
$12.43

Technical Indicators

Market Signals
Indicator
AEIS
IBRX
Relative Strength Index (RSI) 39.09 42.43
Support Level $210.50 $7.72
Resistance Level $350.63 $8.56
Average True Range (ATR) 11.99 0.71
MACD -1.09 -0.13
Stochastic Oscillator 28.11 12.82

Price Performance

Historical Comparison
AEIS
IBRX

About AEIS Advanced Energy Industries Inc.

Advanced Energy Industries Inc provides precision power conversion, measurement, and control solutions. The company designs, manufactures, sells, and services power electronics conversion products that transform raw electrical power into controllable, usable power for complex equipment. It operates in one reporting segment, Power Electronics Conversion Products, serving the Semiconductor Equipment, Data Center Computing, Industrial and Medical, and Telecom and Networking markets. Its products include Plasma Power Products, AC-DC Power Supply Units, DC-DC Converters, High Voltage solutions, SCR Power Controllers, and Sense and Measurement solutions. The company operates in the United States, Asia, Europe, and other regions.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: